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This paper reviews the evidence for host genetic variation in resistance to infectious diseases for a wide variety of diseases of
economic importance in poultry, cattle, pig, sheep and Atlantic salmon. Further, it develops a method of ranking each disease
in terms of its overall impact, and combines this ranking with published evidence for host genetic variation and information on
the current state of genomic tools in each host species. The outcome is an overall ranking of the amenability of each disease
to genomic studies that dissect host genetic variation in resistance. Six disease-based assessment criteria were defined: industry
concern, economic impact, public concern, threat to food safety or zoonotic potential, impact on animal welfare and threat
to international trade barriers. For each category, a subjective score was assigned to each disease according to the relative
strength of evidence, impact, concern or threat posed by that particular disease, and the scores were summed across
categories. Evidence for host genetic variation in resistance was determined from available published data, including breed
comparison, heritability studies, quantitative trait loci (QTL) studies, evidence of candidate genes with significant effects, data
on pathogen sequence and on host gene expression analyses. In total, 16 poultry diseases, 13 cattle diseases, nine pig
diseases, 11 sheep diseases and three Atlantic salmon diseases were assessed. The top-ranking diseases or pathogens, i.e.
those most amenable to studies dissecting host genetic variation, were Salmonella in poultry, bovine mastitis, Marek’s disease
and coccidiosis, both in poultry. The top-ranking diseases or pathogens in pigs, sheep and Atlantic salmon were Escherichia coli,
mastitis and infectious pancreatic necrosis, respectively. These rankings summarise the current state of knowledge for each
disease and broadly, although not entirely, reflect current international research efforts. They will alter as more information
becomes available and as genome tools become more sophisticated for each species. It is suggested that this approach could
be used to rank diseases from other perspectives as well, e.g. in terms of disease control strategies.
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Introduction
Background
Infectious diseases in livestock result in high economic
losses in Europe and worldwide. They also have potentially
major impacts on the safety of European animal products,
especially for food safety, animal welfare and public per-
ception of livestock production industries. Further, due to
the impacts of globalisation, i.e. increased movement of
people and products, and climate change, new disease
threats continue to emerge (Foresight Project, 2006). Hence,
the management of infectious disease is of critical importance
to the European livestock sector and is the subject of
considerable ongoing research.
Disease control strategies include both prevention and
cure, and may comprise decisions affecting the animal (e.g.
vaccination, culling diseased animals, selection of resistant
animals), the pathogen (e.g. chemotherapy) or the envir-
onment (e.g. biosecurity, sanitation). With the recent
development of extensive high-throughput genomic tools
that enable dissection of host responses to infection and
comprehensive descriptions of host genetic variation,
research efforts have increasingly turned to quantifying the
genetic control of the host–pathogen interaction. Much is
promised in terms of identifying critical host genes that may
lead to either vaccine targets or possibilities for breeding
animals for ‘disease resistance’; however, these promises
do need to be critically evaluated. This paper concentrates
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primarily on host genetic variation in disease resistance,
and then evaluates the opportunities to dissect and
potentially exploit such variation.
The use of host genetic variation to help control disease
should always be considered as part of a larger disease
management strategy. Whilst it will be a valuable tool for
some diseases, for other diseases it may be of low priority
in relation to other disease control strategies, or maybe not
even appropriate. A framework is required to determine
when breeding for disease resistance is appropriate, and for
which diseases it is possible to obtain the necessary genetic
information to achieve this. A procedure is required that
defines and ranks the importance of the major pathogens
and infectious diseases of livestock species, and then
overlays this with knowledge of host genetic control of
resistance to each disease and the opportunities to use
genomic tools to obtain such information. To our knowl-
edge, such a procedure or summary does not exist.
This review aims to fill this gap. It briefly reviews the
biology and evidence for host genetic variation in resistance
to a variety of important infectious pathogens and livestock
diseases, including those with the potential for causing food
safety issues. The considered diseases were chosen based
on their overall importance to livestock production indus-
tries in Europe and their likely amenability for host genetics
research. It should be noted that the diseases covered vary
greatly in their impact and also in the production systems
within which they are found. For example, the parasitic
diseases are generally only found in extensively managed
populations, whereas some of the bacterial and viral
diseases discussed are a feature of intensive livestock
production systems. For this reason, the relative importance
of different diseases may change if production systems
change, e.g. if extensive organic production systems
become more widespread.
Transmissible spongiform encephalopathies are excluded
from this review, as they have been adequately addressed
elsewhere. Diseases that previously have not been of
widespread importance in Europe, but have or may become
so with climate change, have been omitted in this review.
These include Trypanosomiasis and Theileria, for which host
genetic variation is well established, and Blue Tongue, a
disease of current and growing concern, which has not yet
been studied from a host genetic perspective.
Host species include poultry, cattle, pig, sheep and
Atlantic salmon. A description of each disease, and its
impacts, has been sourced from current reviews in the field
(European Food Safety Authority (EFSA), 2005 and 2006),
from scientific publications and from industry opinion.
Further, and critically, this review provides a method to rank
diseases according to their overall importance. An overall
score is then assigned to each disease, defined as an
‘operational genomics’ or OG score, which ranks the
amenability of that particular disease to genomic studies
aiming to elucidate host genetic control of resistance. These
scores can be compared both within and between species,
and they can be updated as more information or better
genomic tools become available. It is important to realise
that these scores are not precise: they are somewhat
subjective and will change with changing circumstances,
priorities and tools.
Scoring criteria and ranking process for each pathogen
or disease
Due to the varying impacts of different diseases (mortality,
welfare, food safety risks, public perception and trade
barriers), it is not obvious how to devise an objective sys-
tem for ranking the importance of contrasting diseases.
However, subjective ranking systems based on published
data and expert opinion may be used for this purpose (e.g.
Perry et al., 2002), with subjectively assigned scores then
combined across assessment criteria. Six disease-based
assessment criteria were defined:
1. The industry concern was established through direct
contact with the livestock industry, specifically with
breeding associations and pharmaceutical companies,
and reflected the importance of the disease risks/
problems at the present time, including perceived risk of
emerging diseases.
2. The economic impact reflected figures for actual losses,
where figures were not available, the industry views
were used.
3. The public concern was centred upon present scares/
worries and press coverage.
4. The threat to food safety/zoonotic potential was based
upon numbers of reported disease cases as well as the
potential for some pathogens to become zoonotic.
5. The impact on animal welfare was based upon the
overall impact on the animal (e.g. clinical signs and
long-term effects on immune system).
6. The threat to international trade barriers was centred on
the effect a disease may have on international trade and
on possible resulting trade barriers.
For each category, a subjective score (1, 2 or 3) was
assigned to each disease according to the relative strength
of evidence, impact, concern or threat posed by that par-
ticular disease. Where no evidence or impact could be
ascertained, no score was given. The total disease score (7),
which reflected the overall importance of the disease, was
then defined as the sum of the score numbers assigned to
each pathogen, for scoring criteria 1 to 6.
The disease-based scores were then combined with data
describing host genetic effects and genomic resources. The
evidence for genetic variation (8) was subjectively also
scored, and determined from available published data,
including breed comparison, heritability studies, QTL stu-
dies, evidence of candidate genes with significant effects,
data on pathogen sequence and on host gene expression
analyses. The OG ranking ‘within species’ (9) was calculated
as the disease score, divided by the number of scoring
criteria, plus the genetic variation score; this provided a
measure of the overall suitability of the pathogen or disease
for genomics studies with a strong applied perspective.
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However, different host species currently differ in the
quality and quantity of the available genomic resources,
making disease rankings between species difficult. There-
fore, a second ranking was created to allow comparison of
pathogens and diseases across host species. This rank-
ing was called OG ranking ‘across species’ (10) and was
calculated as the OG ranking ‘within species’ (9) plus a
genome tool score, which took into account the current
status of host genomic tools (see the following section)
available for each host species. For poultry and cattle the
genome tool score was three, for pigs and sheep it was two
and for salmon it was one.
Current status of host genomic tools
For the above-described ranking process and especially to
assign a genome tool score to the host species, two types of
information, both of them dependent on the annotation of
the genome sequence, were considered:
(i) Transcript profiling arrays (expression arrays), which
enable one to have a detailed description of expression
pattern and cascades of genes differentially regulated in
different physiological conditions, e.g. after infection or
disease, and
(ii) High-density single-nucleotide polymorphism (SNP) arrays,
which provide robust marker sets for the construction of
high-density linkage disequilibrium maps and for haplo-
type determination. SNP-based genome scans allow to
perform association analyses for relevant phenotypic traits
at the genome-wide level, e.g. to identify quantitative trait
loci (QTL) related to disease resistance.
Poultry. A web database specific for poultry resources is
readily accessible (GBrowse; Schmidt et al., 2008) and more
than 3 million SNPs are already deposited in GenBank. As a
consequence, several medium-density SNP genotyping
microarrays (the largest containing 20K SNPs, Illumina
Infinium platform) are available for the scientific commu-
nity. At least five commercial expression arrays (Schmidt
et al., 2008) are currently used; additionally, research
groups have developed arrays for specific studies (e.g. low-
density chicken immune system microarray; Brisbin et al.,
2008). The most dense chicken whole-genome expression
array contains 44K features (Afonso et al., 2007).
Cattle. The situation in cattle is similar to chicken and
several commercial microarrays are available, with some
research groups developing their own cell-specific micro-
arrays (e.g. 5K macrophage specific array; Jensen et al.,
2006). Extensive datasets with more than 115K SNP exist
and are available at the National Animal Genome Research
Program (NAGRP, 2007) webpage. Platforms have devel-
oped targeted SNP arrays; Affymetrix one including 10K
SNPs representing 10 different breeds and another with
25K SNPs, which are informative in more than 15 different
beef and dairy breeds. Illumina have made available a third
array, the largest, with 50K SNPs.
Pig. To date, about 75% of the swine genome is under-
going sequencing or is in the pipeline by the International
Swine Sequencing Consortium (SGSC, 2007); realistic pre-
visions indicate that a good coverage sequence (.33) will
be likely completed at the beginning of 2009. A large
number of functional genomic studies have been conducted
(reviewed by Tuggle et al., 2007), mostly using two com-
mercial expression arrays, the largest containing 24K tran-
scripts from Affymetrix. A 7.6K iSelect custom SNP array has
been recently produced and successfully used at the Centre
for Integrative Genetics (CIGENE), while a 50K is currently
under manufacture and should be commercially available by
December 2008 (Groenen MA, personal communication).
Sheep. Sequencing of the sheep genome is not yet avail-
able; however, a whole-genome BAC physical map and a
virtual sheep genome were recently made accessible from
the Commonwealth Scientific and Industrial Research
Organisation (CSIRO, 2007).
Projects for the development of 20K and 60K SNP
arrays, which should be available in mid-2008, are ongoing
and coordinated by the International Sheep Genomics
Consortium (ISG, 2007). Commercial expression arrays for
sheep are not available. However, recent studies report the
successful development of a 20K bovine expression array
used to study transcriptional profiles of sheep resistant and
susceptible to gastrointestinal (GI) nematodes (Keane et al.,
2006), and other successful examples of cross-species
hybridisation of sheep samples on bovine arrays (Diez-
Tascon et al., 2005; Cao et al., 2006).
Salmon. Large-scale resources for salmon are available
from the Salmon Genome Project (Adzhubei et al., 2007;
SGP, 2007); however, they are incomplete due to the lack
of genomic knowledge (e.g. the localisation of the SNPs in
the genome is mainly unknown). For genomic studies
on salmon, expression arrays with differing numbers of
features (3.5, 4, 16 and 17K) have been used (Rise et al.,
2004; Ewart et al., 2005; von Schalburg et al., 2005; Martin
et al., 2007). A first 60K whole-genome array is expected
to be available from late 2008 by CIGENE. Whilst many
SNPs have already been detected and validated (Hayes
et al., 2007), mapping of SNPs to genome locations remains
problematic due to widespread duplication of the salmon
genome.
Major infectious pathogens and diseases of poultry
Ascaridia galli
Ascaridia galli is one of the most common round worms
that infect poultry. Ascaridia is predominantly a problem of
free-range poultry. Heavily infected birds may show droopi-
ness, emaciation and diarrhoea. Initial damage is reduced
feed utilisation efficiency, yet severe infection can cause
death. Anthelmintic treatment removes adult parasites, but
it is the immature stage that causes severe damage. Breed
differences have been observed in response to Ascaridia
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infection; faecal egg counts have been reported to differ
between modern breeds (Permin and Ranvig, 2001; Gauly
et al., 2002; Schou et al., 2003), and these differences have
been shown to be both repeatable and heritable (Gauly
et al., 2002).
As Ascaridia is mainly a problem to free-range poultry,
general industry concern is not great. However, given that
free-range production promotes a natural environment to
the public, routine anthelmintic treatment somewhat com-
promises this ‘natural’ environment. Moreover, the possi-
bility of associated drug residues in foodstuff may increase
public concern and the need for alternative control mea-
sures. When this situation is considered along with the level
of genomic information now available and the evidence for
genetic variation described above, Ascaridia becomes a
good candidate for an OG study.
Avian infectious bronchitis
Avian infectious bronchitis is a coronavirus infection of
chickens, which exhibits much antigenic variation. Infection
is spread rapidly by contact through the conjunctiva or the
upper respiratory tract. Birds can maintain a carrier status
up to 49 days post infection. Industry concern is caused by
the rapid emergence of new strains, resulting in serious
economic loss. Predisposing factors to an outbreak are poor
ventilation and high stocking density. There is a vaccine
available but this offers approximately 3 weeks of protec-
tion. At present much is known about the genomics of the
infectious bronchitis virus (IBV, for an exhaustive example
see Jackwood et al., 2005); however, only a few reports,
indicating a role for IL-6 in IBV-induced nephritis (Asif et al.,
2007) and for the Mannan-binding lectin in innate immunity
against IBV (Juul-Madsen et al., 2007) have been published
on host genetics and resistance. With present knowledge,
this is not a high-ranking OG potential pathogen; however,
given that knowledge of the viral genome is available, if
further host genomic information became available, this
conclusion could change.
Avian influenza
Avian influenza, commonly known as bird or Avian flu, is a
highly contagious viral disease affecting the respiratory,
digestive and/or nervous system of many species of birds.
The virus is enzootic in poultry in several countries in Asia
and it is present in more than 50 countries worldwide.
Typically the disease presents suddenly with affected birds
showing oedema of the head, cyanosis of the comb and
wattles, dullness, lack of appetite, respiratory distress,
diarrhoea and a drop in egg production. Transmission is via
direct contact with secretions from infected birds, con-
taminated feed, water and equipment. Apart from current
concerns, the most recent serious outbreak in Europe
occurred in 2003 in the Netherlands, Belgium and Germany,
and caused 28 million poultry to be slaughtered. The latest
large-scale outbreak, which also spread to the European
Union (EU), occurred in late 2005 in China and south East
Asia and has resulted in a number of human deaths.
Avian influenza is therefore a potential zoonosis (for a
review of the zoonotic risk, see Van Reeth, 2007) although
human infection appears to occur only by direct exposure to
infected birds or carcasses. Even though much is known on
the genetics and molecular characteristics of the virus, with
a recent study showing that a mutation in the NS1 gene
affects the pathogenicity of different avian influenza strains
(Jiao et al., 2008), there is little known of the genetics and
immunological factors underlying the host response. Due to
the major concern both to the industry and the public and
to the current potential increase of zoonotic threat, avian
flu could become a candidate for OG research. However,
such research is more likely to be driven by vaccine
requirements than breeding opportunities.
Avian leucosis
Avian leukosis (AL) is a viral disease that causes cancer-like
disease and other production problems. The viral subgroup J
avian leucosis has been a major economic problem for
poultry breeding companies, as vertical transmission is
common. However, eradication strategies are in use; these
involve testing hens and removing infected hens, and this
disease has now been eradicated from all primary breeders
of layers and broilers.
The major histocompatibility complex (MHC) B alleles
have been found to play a major role in resistance to AL
viraemia and tumour development (Bacon, 1987). A link
between MHC genotype and the risk of becoming a virus
shredder has also been reported (Yoo and Sheldon, 1992).
Bumstead (1998a) described how resistance to some strains
of ALv are inherited as a single dominant gene and this
gene has been identified and its function determined as
coding for the viral receptor (Young et al., 1993). However,
the exact chromosomal location of this gene is yet to be
determined. Recent studies confirm the effect of B haplo-
types on response to infection and also report line differ-
ences explained by other genetic factors that appear to
have a stronger influence (Williams et al., 2004; Mays et al.,
2005). Although much evidence for host genetic variation
has been described, at present this is not a potential
pathogen for an OG study as industry concern is reasonably
low and there is no zoonotic risk.
Campylobacter spp.
Campylobacters are a significant cause of enteritis in
humans; in 2004 183 961 and in 2005 197 363 recorded
cases of campylobacteriosis were reported from 21 and 22
EU member states, respectively (EFSA, 2005 and 2006). The
majority of these cases came from consumption of infected
poultry products. The most common species to cause
human infection was Campylobacter jejuni followed by
C. coli. C. jejuni infection is not pathogenic in poultry and
exists in a carrier state in the hindgut, and bacteria is then
shed via the faeces. As a result of birds showing no clinical
signs, campylobacter infection is often left untreated in
production animals, thus providing a reservoir from which
campylobacter can then enter the food chain. However, it
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may be possible to reduce the number of bacteria within
this reservoir using host genetics. Boyd et al. (2005)
observed a 10- to 100-fold difference between four inbred
lines in the number of C. jejuni organisms present in the
cloaca or in the caeca, with the greatest differences
detected between lines that carried relatively high bacterial
levels and those that carried relatively low numbers of
bacteria. This implicates a genetic component controlling
the proliferation of these bacteria, suggesting that it may be
possible to manipulate host genetics such that the bacterial
load decreases. Hence, the resulting transmission to
humans should also decrease. Therefore, Campylobacter
could be a potential candidate pathogen for an OG study.
Coccidiosis
Coccidiosis is an economically important intestinal parasitic
disease of poultry caused by Eimeria infection. The cost of
coccidial infection in the UK (circa 780 million broilers) is at
least £42 million per annum (Williams, 1999). 74% of this
cost is due to the sub-clinical effects on weight gain and
feed conversion efficiency and 24% is due to the cost of
prophylaxis and therapy of infected birds. Eimeria infection
is generally controlled by prophylactic in-feed medication;
however, in Europe this control method may be lost due to
the withdrawal of coccidial drugs and rising levels of drug
resistance. Thus alternative efficient strategies are needed.
Chickens can be infected by seven species of the intra-
cellular apicomplexan protozoan parasite Eimeria. Genetic
differences in resistance observed in inbred lines have been
reported for all seven species (Bumstead and Millard,
1992). Differences were also reported between IAH light
Sussex chickens and the same inbred lines (Smith et al.,
2002). Large differences have also been reported in outbred
populations both for resistance to infection and for the
impact of infection on production traits (Pinard-van der
Laan et al., 1998). A QTL has been identified that is asso-
ciated with oocyst shedding (Zhu et al., 2003). Coccidiosis
has OG potential, as alternative controlling strategies are
required in the near future. Therefore this requirement,
combined with the depth of genomic information available
for poultry, provides a strong basis for an OG approach.
Dysbacteriosis
Dysbacteriosis is a poorly defined, non-specific bacterial
enteritis, which is mainly seen in rapidly growing broilers.
There appears to be no single bacterium responsible and it
appears that the condition is caused by a disruption of the
normal gut flora. This condition causes inflammation of the
small intestine and results in wet litter, which then leads
to footpad lesions (pododermatitis). In severe outbreaks
prophylactic anti-microbial treatment may be necessary. The
economic loss is as a result of the drop in growth rate.
There is no published evidence on the genetics of the
underlying host response, and although this is of serious
concern to industry and a significant welfare issue, it is not
a potential disease for an OG study.
Escherichia coli
In 2004, 4143 and in 2005 3217 cases of E. coli infection in
humans were reported in 17 and 18 EU member states,
respectively, from various types of livestock (EFSA, 2005
and 2006). Various strains of E. coli bacteria infect poultry.
In general, E. coli infection has a direct effect on the mor-
tality and morbidity of the birds. Some strains that infect
poultry are potentially zoonotic and may cause food poi-
soning in humans; however, infection with these strains is
relatively uncommon. The strains that are most pathogenic
to humans are generally not found in poultry products.
Some success has been reported in finding genetic
markers associated with E. coli antibody response, asso-
ciations have been found within the MHC complex (Lavi
et al., 2005) and also throughout the genome (Yunis et al.,
2002). This pathogen has some potential for an OG
approach; however, the low risk to public health from E. coli
in poultry suggests that this pathogen may be better
studied using OG in a different host species.
Infectious bursal disease
Infectious bursal disease (IBD) is an immunosuppressive
viral disease of poultry, which manifests with clinical signs
in birds over 2 weeks of age. Morbidity can be up to 100%
and mortality between 0% and 50%. The clinical disease is
highly contagious with an incubation period of 2–3 days;
affected birds can excrete the virus for 2 weeks post
infection. The virus is highly resistant and can survive in
housing and faeces for several months. This disease has
direct economic effects through production losses, and also
long-term losses due to damaged immune systems. The
severity of the damage is linked to the age at which the
damage occurred, with the most severe damage occurring
in younger birds. There is no specific treatment; however,
antibiotics may be used to combat secondary infections.
Line differences in mortality have been observed, which
were suggestive of genes with major impacts on resistance
(Bumstead et al., 1993). It was also shown that MHC alleles
were associated with vaccine response and disease severity
in previously vaccinated birds. Large breed differences have
been reported in mortality rate following challenge with
the acute clinical form (vvIBDV) of this pathogen (Hassan
et al., 2004). IBD has some potential for OG due to the
evidence of genetic variation and the depth of poultry
genomic information available. However, as it does not
cause major concern to industry and has no zoonotic risk,
it is not an OG priority.
Marek’s disease
Marek’s disease (MD) is a lymphoproliferative disease of
chickens and turkeys caused by the MD virus, an oncogenic
a-herpes virus. It is characterised by immunosuppression
and the development of tumours in various organs. Morbidity
within an infected flock is between 10% and 50% with
mortality up to 100%. Once infected, birds remain viraemic
for life. The route of infection is generally respiratory and
the virus is highly contagious. There is no treatment for MD
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and prevention strategies involve vaccination when 1-day
old with a combination of vaccines to offer broader pro-
tection. However, throughout the 1980s and 1990s, highly
virulent strains have become problematic in Europe and
North America and alternative control strategies are now
sought as the vaccines are becoming less effective. MD is
the most serious chronic disease in the poultry industry and
it has a huge economic impact, with losses caused by
mortality, reduced egg production and meat contamination.
Even 20 years ago, MD-associated costs were estimated at
close to $1 billion (Purchase, 1985).
Evidence for genetic differences in resistance to MD was
first published by Cole (1968) and later reviewed by Gavora
and Spencer (1979). Involvement of the MHC locus and
specifically the discovery that chickens heterozygous or
homozygous for the B 21 allele were resistant to MD
infection were also major findings in the research on this
pathogen and also in animal disease genetics (Briles et al.,
1977; Longenecker et al., 1977). Genetic management of
MD is well established in intensive poultry systems with
selection on response to infection (Friars et al., 1972) and
specific B alleles within the MHC (Bacon, 1987). However,
concurrent vaccination strategies, whilst enabling poultry
production to continue, have most probably generated more
pathogenic strains of MDv following each new vaccine
(Witter, 1998). QTL associated with resistance to MD,
including proliferation of tumours, survival and viraemia,
have now been identified (Bumstead, 1998b; Vallejo et al.,
1998; Yonash et al., 1999). Cheng (2005) identified QTL in
commercial populations and found indications of QTL that
were common across populations. This group has also
reported several novel host–pathogen interactions, with
the identification of the growth hormone gene as a candi-
date MD resistance gene. At present MD is the best
example in poultry where disease control strategies can
utilise host genetics, with tools provided through the
application of OG.
Mycoplasma spp.
Mycoplasmas are the smallest self-replicating organisms
known. Mycoplasma gallisepticum and M. synoviae are
important pathogens that cause respiratory disease in poultry
and wild birds. There is some industry concern at present as
these pathogens are becoming endemic in free-range layers,
due to exposure to infected wild birds. These pathogens have
a major economic impact, particularly when infection is
concurrent with other respiratory diseases. For both patho-
gens, infection is via the conjunctiva or upper respiratory tract.
M. gallisepticum causes slow-onset chronic respiratory dis-
ease in layers and severe sinusitis in turkeys. Birds may
appear to recover; however, they will remain infected for life
and stress may cause recurrence of the disease. M. synoviae
affects chickens and turkeys and causes synovitis and air
sacculitis. The disease spreads rapidly and is a significant
problem in commercial layer flocks; however, mortality is
usually less than 10% and the morbidity is between 2%
and 15% (The Merck Veterinary Manual, 2005). Unlike
M. gallisepticum, birds can recover and previously infected
birds develop some immunity.
Both of the infections described respond to antibiotic
treatment; however, again this increases the risk of drug
residues in food products. At present, there is no published
evidence regarding the genetic control of host response to
Mycoplasma spp. infection, although information has been
published on the pathogen genomics and on molecular
mechanisms of phenotypic variation in pathogenesis
(Noormohammadi, 2007). At present, this is not a target
pathogen for OG.
Necrotic enteritis
Necrotic enteritis is an acute or chronic enterotoxaemia
seen in chickens, turkeys and ducks worldwide. Necrotic
enteritis can cause significant mortality in broilers in their
rapid growth phase. This condition is caused by infection
with Clostridium perfringens and is characterised by fibrino-
necrotic enteritis, usually of the mid-small intestine. Clinical
signs include depression, inappetance, immobility and
diarrhoea. Treatment is usually with antibiotics; however,
management practices can involve the addition of penicillin
to foodstuffs as a preventive measure, which will increase
the risk of drug residues in poultry-derived food products.
At present there is no published evidence of host
genetic variation in resistance to this disease. Necrotic
enteritis is of decreasing importance to industry, and at
present is not of significant industry concern. The decrease
in concern, combined with the lack of genomic information,
suggests that necrotic enteritis is a poor candidate for OG
studies.
Newcastle disease
Newcastle disease (ND) is a highly contagious and fatal
virus affecting all species of birds; however, currently it is
not endemic in Europe. For more than 30 years it has been
known that variation exists between birds in their ability to
cope with infection, specifically in their mortality post
infection (Gordon et al., 1971). Evidence for genetic varia-
tion for antibody response to ND vaccines in turkeys has
also been reported, with a heritability greater than 0.3
(Sacco et al., 1994). Tsai et al. (1992) demonstrated
differences in ND mortality in turkey lines selected for
performance traits, where meat production was adversely
correlated with survival. Large breed differences in mortality
have been observed following NDv challenge (Hassan et al.,
2004) and a QTL associated with antibody response has
been identified (Yonash et al., 2001).
ND is not a major problem in Europe; however, outbreaks
may still occur and work in this disease is important, as
it is still endemic in many countries. In the UK, birds are
not routinely vaccinated against ND; therefore a major
outbreak would have serious economic implications.
Although evidence for genetic variation has been described
and ND potentially poses serious risks, it is not a good
OG candidate from a European perspective, as outbreaks
are rare.
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Red mite
Red mite is an external parasitic infection of chickens and
turkeys caused by the mite Dermanyssus gallinae. These are
blood-sucking parasites that can cause anaemia and death
in young birds; however, the major economic loss is through
infection of layers and broiler breeders. In adult birds red
mites cause a loss of condition and a drop in egg produc-
tion. Red mite is treatable with topical insecticides and
environmental control. A further risk from red mite infection
is the potential to transfer other diseases between birds.
At present there is no published evidence for host genetic
variation in resistance to these parasites, and although
of major economic concern, this is currently not a good
candidate for an OG approach.
Rous sarcoma
Rous sarcoma (RS) is a chicken cancer caused by a retrovirus.
Whilst this disease is of no great economic importance, the
study of this virus has made major contributions to cancer
genetics and may be useful for further studies in other poultry
viral diseases. The possibility of selecting for RS resistance
was first reported by Gyles and Brown (1971); lines were
developed in which tumours progressed or regressed, thus
demonstrating that the genetic effect is not on resistance but
on the ability to control the effects of infection. MHC B alleles
have again been linked to RS (Bacon et al., 1981; Hala et al.,
1998; Kaufman and Venugopal, 1998) as with other viral-
induced poultry tumours. Young et al. (1993) indicated a gene
associated with resistance and Pinard-van der Laan et al.
(2004) described divergent selection for tumour progression
in populations homozygous for the B19 MHC allele. This virus
was included in this review as an example of animal disease
research contributing to progress made in human diseases.
Research carried out on this disease may provide useful
methods and tools for use in implementing OG in livestock
diseases.
Salmonella spp.
In 2004, 192 703 and in 2005, 176 395 cases of human
Salmonella infection were reported in the EU. The majority
of these infections can be attributed to Salmonella enter-
itidis and S. typhimurium (from various host species) (EFSA,
2005 and 2006). S. enteritidis infections are commonly
associated with consumption of broiler meat and eggs, and
S. typhimurium with affected meat products. In the past
5 years, Salmonellosis caused by poultry products has
increased significantly in US (Callaway et al., 2008).
Salmonella infection occasionally causes clinical signs in
poultry, such as diarrhoea and loss of appetite, but sub-
clinical infections are very common, where the bacteria
is present in a carrier state within the intestine and
consequently is shed with the faeces. S. pullorum and
S. gallinarum can cause mortality in poultry; however, they
are rarely found in commercial systems. Salmonella infec-
tions in poultry are usually treated with antibiotics and
vaccination programmes (reviewed by Barrow, 2007);
however, the development of antibiotic resistance and also
concern regarding drug residues in food have led to the
need for alternative control strategies.
Research has shown genetic differences in resistance, par-
ticularly resistance to S. enteritidis, and also to other serovars.
Line differences in resistance to infection are well documented
(Bumstead and Barrow, 1993; Barrow et al., 2004) and QTLs
have been identified for resistance or antibody response
(Mariani et al., 2001; Yunis et al., 2002; Tilquin et al., 2005).
Associations have also been reported with a variety of can-
didate genes (Kramer et al., 2003; Malek et al., 2004), which
include MHC polymorphisms (Liu et al., 2002) and NRAMP
(Hu et al., 1997; Lamont et al., 2002; Liu et al., 2003). Gene
expression differences in response to the bacteria have been
found (Van Hemert et al., 2006 and 2007), as well as sig-
nificant changes in cytokine expression (Kaiser et al., 2006)
and in common processes in the chicken intestine (Van Hemert
et al., 2007). Clearly, host genetic variations to Salmonella
infections in poultry are being studied extensively and, given
the developed state of chicken genomic tools, Salmonella is a
high-priority candidate for OG studies.
Summary
Table 1 shows a summary of the 16 poultry pathogens and
diseases, ranked as previously described. The top-ranking
diseases from an OG perspective are infections caused by
Salmonella spp., MD and Coccidiosis. MD is currently the
best example of a disease that has been subjected to an
OG approach, and Coccidiosis has arguably been under-
researched, particularly as it is economically very important,
and strong evidence of genetic variation has been reported.
Major infectious pathogens and diseases of cattle
Bacterial pneumonia (Mannheimia haemolytica)
Bacterial pneumonia has several causative agents; however,
it is most commonly caused by the Gram-negative bacteria
M. haemolytica. M. hemolytica produces two key virulence
factors, leukotoxin (LKT) and lipopolysaccharide (LPS), which
are known to be essential in inducing the pathological
changes. The disease manifests as a fever, mucopurulent
nasal discharge, coughing, with breathing that is rapid and
shallow. Pleurisy may develop in severe cases. Infected ani-
mals exhibit poor body condition and associated economic
loss, due to unthriftiness post infection. This disease can be
treated with antibiotics, which again raises public concern due
to the risk of drug residues entering the food chain.
There is some evidence for genetic effects on resistance
as a study by Muggli-Cockett et al. (1992) observed breed
differences in susceptibility to several respiratory diseases
caused by viruses and bacteria. More recently, heritable
variation in resistance to bovine respiratory diseases, i.e.
any bacterial and viral respiratory infection, has been
demonstrated in feedlot cattle (Snowder et al., 2005 and
2006). Specifically for M. hemolytica, recent research efforts
have determined 90% of the genome sequence of a virulent
serotype of the pathogen (Roehrig et al., 2007), identified
host upregulated genes in response to infection (e.g. TAP,
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NFKB, IL8, ICAM1; Caverly et al., 2003) and elucidated the
pathway by which LKT induce apoptosis of BL-3 cells
(Atapattu and Czuprynski, 2005). Furthermore, it has been
found that the functional receptor for M. haemolytica LKT is
the CD18 subunit of beta(2)-integrins (Dassanayake et al.,
2007) and that the I-EGF-3 domain of CD18 is essential in
conferring species-specific susceptibility to M. haemolytica
(Dileepan et al., 2007). This disease may become a strong
candidate for an OG approach, but currently little is known
about the underlying host genetics.
Bovine leukaemia
Bovine leukaemia is a viral disease of cattle caused by an
exogenous retrovirus that is closely linked to human T cell
leukaemia viruses. When the virus is present, not all cattle
in the herd become infected and, of those that do, only
2–5% go on to develop tumours. Tumours are commonly
found in the uterus, abomasum, heart and external lymph
nodes. Transmission of this disease is via infected blood,
and vertical transmission can occur to the foetus and also to
calves via infected milk. At present there is no zoonotic
threat from this virus.
There is some evidence for host genetic influence as
associations have been reported between resistance to this
disease and MHC alleles, particularly DRB3 alleles (Mirsky
et al., 1998; Udina, 2007). Although evidence for genetic
variation in the host response has been reported for Bovine
leukaemia infection, this is not a high-priority candidate for
OG as industry concern is lower than for many other dis-
eases, due to the relatively low morbidity of this condition.
Bovine tuberculosis
Bovine tuberculosis (TB) is a chronic infectious and contagious
disease of cattle caused by the Mycobacterium bovis. It is
characterised by the development of tubercles in any organ of
the body. Clinical signs include weakness, loss of condition,
inappetance, swelling of lymph nodes, persistent coughing and
respiratory distress. Aerosol exposure is the main route of
infection, and wildlife reservoirs of infection are often impli-
cated in the disease epidemiology. Economic loss occurs due,
firstly, to a loss of stock and, secondly, to the cost of repla-
cement animals. Bovine TB is zoonotic and may be transmitted
to humans through unpasteurised milk and dairy products.
At present, control is through routine skin testing of all cattle
and immediate culling of any animal exhibiting a positive
reaction. The total number of human cases of TB (119) due to
M. bovis reported in 2005 increased by ca. 25% compared
to 2004 (EFSA, 2005 and 2006). However, vaccinations
have significantly reduced human infections and the risk of
contracting the disease from domestic animals has also
decreased in recent years. As yet there is little evidence of
genetic variation in the host response to TB in cattle,
although substantial evidence exists in deer (Mackintosh
et al., 2000) and humans. However, one study has reported
an involvement of the NRAMP1 gene in the modulation
of the cattle immune response to M. bovis (Zanotti et al.,
2002). Although much work has been done on vaccine
development none are commercially available and are not
likely to become available in the near future. Bovine TB
therefore is a good candidate disease for an OG study as it
causes considerable economic loss, it is a public health risk
and is of major concern to industry, and there is likely to be
host genetic variation in resistance.
Bovine viral diarrhoea
Bovine viral diarrhoea (BVD) is a widespread viral disease of
cattle, which can cause considerable economic loss. The
most common signs of BVD are fever, sudden drop in milk
Table 1 List and scores1 of infectious poultry disease
Pathogen/disease
Industry
concern
Economic
impact
Public
concern
Zoonotic
potential
Animal
welfare
International
trade
Disease
score
Genetic
variation
OG rank within
species
OG rank
across species
Salmonella spp. 2 2 3 3 2 12 3 5 8
Marek’s disease 3 3 1 1 8 3 4.3 7.3
Coccidiosis 2 3 1 2 8 3 4.3 7.3
E. coli 2 2 2 1 3 10 2 3.7 6.7
Newcastle disease 1 3 3 3 10 2 3.7 6.7
Infectious bursal disease 3 1 3 8 2 3.3 6.3
Ascaridia galli 2 2 1 2 7 2 3.2 6.2
Rous sarcoma 0 3 3 6
Avian leukosis 1 1 2 4 2 2.7 5.7
Avian influenza 3 3 3 1 3 3 16 2.7 5.7
Campylobacter spp. 2 1 1 3 7 1 2.2 5.2
Avian infectious bronchitis 3 3 1 2 9 1.5 4.5
Necrotic enteritis 3 3 1 2 9 1.5 4.5
Red mite 3 3 3 9 1.5 4.5
Mycoplasma spp. 2 3 2 1 8 1.3 4.3
Dysbacteriosis 2 3 3 8 1.3 4.3
OG5 operational genomics.
1The scores (1, 2 or 3) indicate the relative strength of evidence, impact, concern or threat posed by each disease, with an absence of evidence indicated by no
assigned value.
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yield and diarrhoea. The virus is shed by infected animals
via nasal discharge, faeces, urine, semen and saliva, and
infection is by direct contact. This virus can be transmitted
from mother to foetus, and these infected calves become
major sources of infection as they remain infected for life
and continually shed the virus. Although infection with this
pathogen causes mild clinical signs and very rarely death,
it is the period of time post infection that is important.
Following infection with BVD, animals undergo a period
of immunosuppression during which they are highly sus-
ceptible to other pathogens, e.g. mastitis, pneumonia, calf
scours, and usually these develop into severe illness. In
some cases BVD causes infertility, which contributes to
economic losses along with a drop in milk yield and sec-
ondary infections. Also, recent evidences indicate that BVD
abrogates respiratory innate immune responses and pre-
disposes to bacterial pneumonia in cattle (Al-Haddawi
et al., 2007). A vaccine is available and the virus poses no
zoonotic risk. At present no genetic variation has been
reported for BVD resistance, and as a result BVD is not an
appropriate disease for an OG study.
Brucellosis
Brucellosis, described as ‘contagious abortion’, is caused by
the bacterium Brucella abortus, which can infect both cattle
and humans. In 2004 and 2005, respectively, 1337 and
1218 cases of Brucellosis were reported in humans from the
EU member states (EFSA, 2005 and 2006). In herds where
this disease is endemic, a cow will abort with the first
infection yet subsequent gestations appear normal. The
aborted or premature foetus and placenta are highly
infective and can infect other stock by direct contact.
B. abortus is also excreted in the milk, which can infect the
calf and also humans if unpasteurised milk is consumed.
Brucellosis was eradicated from the UK in 1979; however,
it is still present in many EU member states and sporadic
outbreaks occur from imported stock. Because this disease
is a serious zoonosis, it is important that it is brought under
strict control in all EU member states in order to decrease
the number of cases seen in humans. This disease is not a
good candidate for OG as there are already control and
surveillance techniques implemented in many countries.
However, it remains a threat to public health.
E. coli
E. coli is present in the intestines of all cattle. There are
many strains of E. coli that are pathogenic and zoonotic,
and the most problematic strain from a zoonotic perspective
is E. coli 0157. E. coli 0157 causes food poisoning in
humans that is potentially life threatening; clinical signs
include diarrhoea, haemorrhagic colitis and haemolytica-
uremia syndrome. Cattle are the most important source of
E. coli 0157; infection in cattle is sub-clinical and the
duration of bacterial shedding is variable and intermittent.
E. coli 0157 is a worldwide threat to public health and
the bacterium has been the subject of many studies.
However, as yet there are no published studies on the
genetics of resistance of the host animal. Although E. coli
may become a potential candidate for an OG approach,
currently there is insufficient evidence of host genetic
effects to give it a high ranking.
Foot and mouth disease
Foot and mouth disease (FMD) is an acute infectious viral
disease that affects cattle, pigs, sheep, goats and deer. For
brevity it will be described in this section and the following
sections on other species will refer back to this description.
FMD typically causes fever and blisters, chiefly in mouth
and on feet. As a result of these blisters, animals become
reluctant to eat and become progressively lame. FMD virus is
extremely infectious and spreads rapidly if uncontrolled. In the
EU it is a notifiable disease and control measures involve
immediate slaughter of all livestock on infected premises.
During an FMD outbreak animal movement is restricted to
prevent further spread of disease. The virus can be spread by
blister fluid, saliva, milk, faeces and can travel airborne for
several miles. Also, recovered animals can develop a carrier
status that lasts for up to two and a half years.
FMD outbreaks cause great economic loss through stock
being destroyed and also through disruption of interna-
tional trade. There is no readily available published work on
genetic variation in FMD resistance at present. In the EU it
is not a disease that is treated; however, in other parts of
the world where FMD is endemic, it is conceivable that such
studies will be carried out in future. This is not a potential
pathogen for an OG study as it is not endemic within the
EU, outbreaks are sporadic and control is through slaughter
of infected stock.
Gastrointestinal parasites
Ruminant GI parasitism is perhaps the most important
livestock disease on a global basis (Perry et al., 2002) and
it affects all pasture-based production systems. The pre-
dominant GI parasite of cattle in temperate regions is
Ostertagia ostertagi. The economic consequences of GI
parasitism arise through loss of production as GI parasites
damage the intestinal tract, resulting in reduced nutrient
uptake and retention. Traditional management of this pro-
blem is with anthelmintic compounds. However, routine
anthelmintic usage is expensive, increases the risk of drug
residues in foodstuffs and is comprised by the development
of anthelmintic resistance.
Faecal egg count of cattle, an indicator of relative
infestation levels, is under genetic control, with reported
heritabilities close to 0.3 in temperate (Gasbarre et al.,
2001) and sub-tropical cattle (MacKinnon et al., 1991). QTL
studies of nematode resistance are advanced (Sonstegard
and Gasbarre, 2001); however, evidence from sheep sug-
gests that resistance is polygenic and QTL accounting for
large proportions of the variation may be difficult to find.
GI parasitic infection has the potential to be suitable for an
OG study as there is significant evidence for some genetic
variation, it is of concern to industry and alternative control
measures are needed in the near future due to the reduced
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efficacy of anthelmintics. These factors, along with the
advanced level of bovine genomic information now avail-
able, make GI parasitic infection a potential OG candidate.
Infectious bovine rhinotracheitis
Infectious bovine rhinotracheitis (IBR) is a highly infectious
respiratory disease caused by bovine herpes virus-1 (BHV1).
There are various strains of BHV1 that exhibit different levels
of virulence. Morbidity from IBR can be 100%; however,
mortality is generally low, between 2% and 12%. The dis-
ease manifests with a sudden onset of fever and anorexia,
followed by nasal legions, nasal discharge, coughing and
conjunctivitis. IBR can be fatal in newborn calves as it causes
encephalitis. The disease is spread through aerosol infection
via nasal discharges and coughing. Economic losses occur
whilst animals are infected, due to poor growth, aborted
calves and rapid decreases in milk production. However,
there is no zoonotic risk from this pathogen.
Vaccines are available, but again drug-based disease
solutions are not ideal in the present climate of consumer
concern over drug residues in food products. There is
reported evidence of genetic variation, as this virus was one
of a group of respiratory disease causing pathogens studied
by Muggli-Cockett et al. (1992), which reported breed dif-
ferences were in susceptibility to these respiratory patho-
gens. However, IBR is currently not an OG candidate disease
as not enough is known about the underlying genetics of
the host response. If stronger evidence is published in the
future then this may change, as it is a disease of significant
industry concern.
Leptospirosis
Leptospirosis is an acute bacterial infection of cattle. Most
commonly in cattle it is caused by two species of Lepto-
spira, which manifest in dairy cattle as a drop in milk yield,
poor fertility and abortions and in beef cattle as poor fer-
tility and an increase in abortions. Infection is via infected
urine either by direct contact or through contaminated
water or pasture. Infected animals may be carriers for life;
however, there is a vaccine available. Leptospira infection is
zoonotic and it is therefore a public health hazard. It causes
flu-like clinical signs in humans with a persistent headache,
fatalities are rare but do occur. Transmission can be via
direct contact with infected animals or via infected water-
courses. Unlike in cattle infections, there is currently no
vaccine available for use in humans. No figures were
available on incidence and cost of this disease at the time
of writing. Also, no evidence of genetic variation in
response to this infection has been reported; thus this is not
a suitable pathogen for an OG approach.
Mastitis
Mastitis is an infectious disease causing major economic
losses to the dairy industry. It is characterised by a mild,
sub-clinical or acute (clinical) inflammation of the mammary
gland, which in its severe form causes visibly abnormal milk
(e.g., colour, fibrin clots) and, as inflammation increases,
changes in the udder (swelling, heat, pain and redness).
Mastitis in cattle is usually caused by bacterial organisms such
as Staphylococcus spp., Streptococcus spp., Pseudomonas
spp., Mycoplasma spp. and various coliforms such as E. coli.
Mastitis incidence in the dairy industry has been estimated at
30% of cows per year, and each case has been estimated to
cost between 150 and 300 euros per diseased cow.
At present, selection to reduce the incidence of mastitis is
carried out using udder conformation, somatic cell count
(SCC) and mastitis infection history, with the latter two
having low heritabilities in the range 0.05 to 0.15. Mastitis
incidence is positively correlated with both SCC (ca. 0.7;
Carle´n et al., 2004; Heringstad et al., 2006) and aspects of
udder conformation (up to 0.37; Van Dorp et al., 1998). This
suggests that mastitis resistance may be due not only to
immune responses but also to structural attributes of the
udder or teat. Many QTL associated with mastitis resistance
traits have been reported on almost all of the 29 bovine
chromosomes (see reviews: Khatkar et al., 2004; Rupp and
Boichard, 2003). Joint analyses of three Nordic cattle
populations confirmed QTL affecting clinical mastitis or SCS,
or both, on chromosomes 9, 11, 14 and 18 (Lund et al.,
2007). QTL have been detected in a variety of breeds
including US, German and Dutch Holsteins, Finnish Ayrshire,
Swedish Red and White, Danish Red and Norwegian Cattle
and have been identified close to various plausible candi-
date loci, including MHC and interferons. Considerable
ongoing work addresses the genetic analysis of field data,
identification of loci associated with resistance, host tran-
scriptomic and proteomic responses to infection, and the
definition of new and more precise phenotypic indicators of
infection and immune activation (e.g. neutrophil activity).
Therefore mastitis is, and will remain to be, a high-priority
disease for OG studies.
Paratuberculosis (Johne’s disease)
Paratuberculosis, also known as Johne’s disease, is a bac-
terial infection of the GI tract and is characterised by
chronic diarrhoea, persistent weight loss, decreased milk
production and eventually death. The disease is not treat-
able and vaccinations do not prevent infection; therefore,
economic loss is substantial in both the dairy and beef
industries. Conflicting opinions have been published that
indicate a potential link between the causative agent
(Mycobacterium avium subspecies paratuberculosis) and
Crohn’s disease in humans, via the consumption of infected
dairy products (Chiodini and Rossiter, 1996; Bakker et al.,
2000). Crohn’s disease is a severe inflammatory bowel
disease for which there is no cure. Hence, Paratuberculosis
is potentially a serious zoonotic risk and further investiga-
tion into this link is essential.
Studies of infection status of cattle have indicated that
susceptibility to M. avium sub. paratuberculosis infection is
heritable, with heritability estimates ranging from 0.06 to
0.18 (Koets et al., 2000; Mortensen et al., 2004; Gonda
et al., 2006). Evidence of genetic variation in host response
to this disease has been reported and a QTL affecting
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susceptibility has been mapped recently in US Holsteins to
BTA20 (Gonda et al., 2007). Because the diagnosis of
infected animals represents a major problem, para-
tuberculosis is not a good candidate for an OG approach;
however, this may change if new diagnostic tests become
available, which more easily enable the quantification of
host genetic variation.
Salmonella spp.
Salmonellosis of cattle is commonly caused by one of three
Salmonella serovars, S. typhimurium, S. Dublin or S. Newport.
Salmonella is usually endemic within an infected herd as a
sub-clinical infection with sporadic outbreaks occurring.
During these outbreaks affected animals develop acute
enteritis. Treatment is difficult as use of anti-microbial
can disrupt the gut flora and cause more problems. Also,
Salmonella exhibits multi-drug resistance in both cattle
and humans. Salmonella is a public health hazard as it is a
food-borne zoonosis that causes food poisoning in humans,
typically fever, vomiting and diarrhoea. There is no pub-
lished evidence at present for genetic variation in resistance
to Salmonella in cattle. Therefore, although it is not yet
ready for an OG approach, this may change in the future if
further data become available.
Summary
Table 2 shows a summary of the 13 cattle pathogens and
diseases, ranked as previously described. The highest
priority disease highlighted by this approach is mastitis.
Although mastitis causes major economic loss to the dairy
industry, has major welfare implications and is a complex
disorder for which host genetic variation is being exten-
sively investigated, it has a low impact on public concern.
Next in the rankings are bovine leukaemia and GI parasites,
which are also diseases of low public concern. The diseases
that score most highly in terms of disease impact in this
ranking, i.e. E. coli, FMD and Brucellosis, are not considered
amenable to an OG approach, either through a lack of
knowledge of host genetic factors or because disease control
is better achieved by other means. In general, however, the
major endemic cattle diseases are strong candidates for OG
due to the developed state of cattle genomic tools.
Major infectious pathogens and diseases of pigs
Atrophic rhinitis
Atrophic rhinitis (AR) is a very common condition in its mild
non-progressive form, leading to inflammation of tissues
inside the nasal passages in young pigs and rarely causing
clinical disease in mature animals. However, progressive
atrophic rhinitis (PAR) is a serious condition of sucking
and growing pigs, caused by infection with Pasteurella
multocidia. This infection causes continual and progressive
inflammation and atrophy of the nose and tissues, which
can result in distortion of the face. Other clinical signs
include sneezing, nasal discharge, conjunctivitis, poor body
condition, difficulty in eating, increased risk of respiratory
diseases and pneumonia. Economic loss occurs as a result
of poorly growing pigs. Only few studies have reported
breed differences and genetic variation (i.e. heritability
estimates) in the host response of growing pigs for resis-
tance to AR (e.g. Lundeheim, 1979 and 1988); hence AR is
not considered to have OG potential at the present time.
Aujeszky’s disease
Aujeszky’s disease (AD) is an economically important pig
disease caused by an alpha herpesvirus (Pseudorabies
virus). At present, industry concern is due to the virus
affecting reproductive performance. The virus can remain
dormant within the nervous system for long periods and
then become reactivated; thus once a herd becomes
infected, the virus remains present in a carrier status.
Table 2 List and scores1 of infectious cattle diseases
Pathogen/disease
Industry
concern
Economic
impact
Public
concern
Zoonotic
potential
Animal
welfare
International
trade
Disease
score
Genetic
variation
OG rank
within species
OG rank
across species
Mastitis 3 3 1 2 9 3 4.5 7.5
Bovine leukaemia 2 2 3 7 2 3.2 6.2
Gastrointestinal parasites 2 2 2 6 2 3 6
Paratuberculosis 3 3 1 2 9 1 2.5 5.5
Bovine TB 2 1 1 3 1 8 1 2.3 5.3
Bacterial pneumonia 3 2 2 7 1 2.2 5.2
E. coli 3 3 3 3 1 13 2.2 5.2
FMD 3 3 2 2 2 11 1.8 4.8
Brucellosis 2 2 1 3 1 2 11 1.8 4.8
IBR 2 2 4 1 1.7 4.7
Salmonella spp. 2 2 3 3 10 1.7 4.7
BVD 3 3 3 9 1.5 4.5
Leptospirosis 2 2 3 1 8 1.3 4.3
OG5 operational genomics; TB5 tuberculosis; FMD5 foot and mouth disease; IBR5 Infectious bovine rhinotracheitis; BVD5 bovine viral diarrhoea.
1The scores (1, 2 or 3) indicate the relative strength of evidence, impact, concern or threat posed by each disease, with an absence of evidence indicated by no
assigned value.
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Transmission of the virus can be via several routes, e.g.
aerosol, airborne (3 km), infected slurry and artificial inse-
mination with infected semen. AD manifests in sows as
coughing, fever, nervous signs and impaired reproductive
function, and the virus can be passed from sow to foetus. In
piglets, clinical signs are sneezing, coughing, nervous signs
and in-coordination. A high mortality rate is often seen in
piglets; however, mortality is lower in older pigs.
Reiner et al. (2002) reported breed differences between
Large White and Meishan animals deliberately infected with
Pseudorabies virus. This study also identified QTL for the
presence/absence of neurological clinical signs and rectal
temperature post infection. It has also been observed that
the presence of porcine reproductive and respiratory syn-
drome (PRRS) or Leptospira can increase the severity of AD.
Thus it is important to study these diseases and also to
further investigate the interactions occurring between dif-
ferent infectious agents. Although there is some evidence
for genetic variation in response to AD and some research
groups are doing microarray studies on the interaction
between AD and porcine cells (Flori et al., 2008), not
enough is known yet to rank this disease highly for an
OG approach.
E. coli
E. coli is a bacteria found naturally in the gut; however,
pathogenic strains can cause diarrhoea in young piglets.
Infection usually occurs between birth and 5 days of age.
E. coli is an important cause of diarrhoea in piglets, and
can cause high morbidity and mortality of up to 50%. It is
possible to vaccinate sows, particularly gilts, in order to
protect the piglets; however, this may be costly and is also
increasing the use of drugs in food-producing animals,
which is a matter of public concern.
Evidence for genetic control of resistance to E. coli
has been known for many years (Sellwood et al., 1975).
Gibbons et al. (1977) published evidence that susceptibility
to E. coli F4ac adhesion is dominantly inherited in the host.
This is characterised by the presence or absence of specific
receptors on the brush borders of enterocytes in the small
intestine; homozygous recessive animals lack the K88
receptor, which enables coliforms to adhere to the gut,
causing diarrhoea. Python et al. (2002) suggested that this
is under the control of one gene, F4bcR, which was local-
ised on chromosome 13. Recent studies identified two
candidate genes (Mucin 4, Peng et al., 2007; Mucin 13,
Zhang et al., 2008) coding for the specific F4ab/ac receptor;
mutations in these genes were strongly associated with
F4ab/ac adhesion phenotypes. A DNA marker-based test
has been also developed to allow genotyping for enter-
otoxogenic (ETEC) F4ab/ac resistance and susceptibility
(Jørgensen et al., 2004). Resistance to E. coli is strain
specific and much of the published work has been asso-
ciated with E. coli F18, a major cause of post-weaning
diarrhoea. The gene controlling expression of the E. coli
F18 receptor (ECF18R) has been mapped on chromosome 6
(Vo¨geli et al., 1996) and a polymorphism at nucleotide 307
in the FUT1 gene (Meijerink et al., 1997) has been shown
by several studies to be responsible for susceptibility to
E. coli F18 infection. This polymorphism can be utilised as
a predictor of susceptibility to diarrhoea caused by E. coli
F18; F18 susceptibility selection is now part of a commercial
marker-assisted selection scheme.
However, all of the studies mentioned above involved
ETEC serotypes of E. coli and much of the ongoing research
on E. coli infection of pigs involves enterohaemorrhagic
(EHEC) serotypes. Therefore, although the evidence of var-
iation in host resistance to E. coli indicates that there may
be considerable opportunities to apply an OG approach to
this pathogen, further research into evidence of genetic
variation associated with infection with EHEC serotypes is
also needed. Notwithstanding, E. coli infections in pigs
remain strong candidates for OG studies.
Enzootic pneumonia
Enzootic pneumonia (EP) is caused by the bacterium
Mycoplasma hyopneumoniae. This highly contagious and
chronic disease is widespread among pig populations
worldwide. M. hyopneumoniae is present in almost every
pig herd (Minion et al., 2004); however, infection with EP
alone is normally uncomplicated and economically not
important. Hence, the EP bacterium can be considered as a
primary pathogen and it is its combination with other
infections that may lead to severe illness. If, for example,
PRRS or Pasteurella are present, the resulting pneumonia
can be very serious. Clinical signs of EP can include pneu-
monia, dehydration, coughing, heavy breathing, respiratory
distress, fever and high mortality. Treatment of EP is limited
to antibiotics that are currently ineffective as they do not
completely remove the infection. Vaccines reduce the
severity but do not prevent the disease from occurring in
infected pigs (Haesebrouck et al., 2004). Ruiz et al. (2002)
investigated half-sib family differences to EP and the results
suggested a possible genetic effect. Besides this, little is
known regarding the underlying genetics of host resistance
to this disease. When more is known, it may be possible to
use OG to investigate these interactions.
Foot and mouth disease
Please refer to the cattle section for a description of FMD.
Although FMD has similar effects in different species, the
scores assigned to FMD vary between species.
Porcine influenza
Porcine influenza (flu) is caused by a number of closely
related influenza A viruses that are noted for their ability to
change their antigenic structure and create new strains. As
a result, different strains of porcine flu exhibit differing
levels of pathogenicity. The disease may become endemic in
large herds with intermittent bouts of disease and resulting
infertility. The disease is characterised by rapid explosive
outbreaks of inappetance and clinically very ill animals.
Clinical signs include coughing, pneumonia and fever. The
effects on reproductive function follow the sudden onset of
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respiratory disease. If combined with other infections (e.g.
EP or porcine reproductive and respiratory syndrome virus
(PRRSV)), an intractable chronic respiratory disease can
develop. Secondary infections can be treated with anti-
biotics, although again this is increasing the risk of drug
residues in food products.
Although the genetics of the virus have been extensively
studied, few studies have been published on host genetic
effects. To date, the only readily available information is a
report of a 11-bp naturally occurring deletion variant in the
MX1 gene that has been shown to be implicated in sus-
ceptibility to the influenza virus (Nakajima et al., 2007).
Currently, this pathogen is not a strong candidate for OG
studies, although independent verification of the MX1 gene
effect would alter this conclusion.
Porcine reproductive and respiratory syndrome
PRRS is a viral infection of pigs that causes major economic
loss and is currently of major concern to the industry. Once
this virus has entered a herd it tends to remain present and
active indefinitely. Transmission can be via several routes,
nasal secretions, saliva, faces and urine from infected
animals, airborne transmission and artificial insemination.
Initially the virus destroys alveolar macrophages, thus
leaving infected animals more susceptible to respiratory
infections such as EP. PRRS manifests in various forms in
pigs of different ages. In sows, PRRS can cause late-term
abortions, prolonged anoestrus, an increase in stillbirths
and mummified piglets, coughing and respiratory problems.
Piglets, from infected sows, are often weak and slow to
develop. Piglets that become infected with PRRS develop
diarrhoea and are highly susceptible to respiratory infec-
tions. Pigs infected at the grower stage often develop
pneumonia and suffer inappetance and wasting. Boars
exhibit a loss of libido, lethargy, inappetance and lowered
fertility. Hence it is a disease that causes considerable
economic loss, being probably the most costly disease to
pig industries of Europe and North America.
PRRS is a complex disease and evidence for the genetic
basis of resistance is growing. Breed differences have been
reported (Halbur et al., 1998; Petry et al., 2005 and 2007;
Vincent et al., 2005 and 2006; Ait-Ali et al., 2007) as
summarised by Lewis et al. (2007), within-breed variation in
apparent tolerance of this disease is now becoming avail-
able (Lewis et al., 2008). From a research perspective, PRRS
has some advantages. Firstly, good in vitro models of
infection exist, and these enable quantification of host
transcriptomic responses (Genini et al., 2008) as well as
breed-level genetic differences (Vincent et al., 2005; Ait-Ali
et al., 2007). Secondly, indicators of the impacts of infection
are relatively easily collected in herds undergoing out-
breaks, e.g. the numbers of mummified piglets, and these
indicators will enable genetic effects to be relatively easily
quantified (see Lewis et al., 2008). Although this is a dis-
ease that still requires much more fundamental research,
it is rapidly becoming an interesting target for an OG
approach.
Post-weaning multisystemic wasting syndrome
Post-weaning multisystemic wasting syndrome (PMWS) is a
multifactorial disease that has recently become a major
source of economic loss to the pig industry. This disease is
present in all major pig-producing countries, and in the EU
the cost of PMWS may be as high as h900 million per year.
The epidemiology and immunology of the syndrome are
largely unknown and much of the available information is
circumstantial. PMWS causes wasting and depression and
usually appears between 6 and 14 weeks of age, although
once a herd is infected clinical cases may continue to
appear for several months, usually peaking between 6 and
12 months. The syndrome appears to manifest as a
response to multiple viral infections. It is known that the
PCV2 virus is a necessary agent; however, this alone does
not cause disease and most clinical cases present PCV2 as
well as another virus. It is estimated that 90% of pigs have
been exposed to PCV2, which is transferred via oro-nasal
transmission, yet the onset of disease and resulting mor-
tality can be strongly affected by the pathogens already
endemic within the herd. Mortality can be as high as 80%.
The control of this syndrome is critical to the industry;
however, standard biosecurity measures have failed to work
and it is now essential to define the epidemiology and
immunology of this condition. It is also important to investi-
gate the apparent interactions between PCV2 and other viral
infections. As so many aspects of PMWS are as yet unknown,
it is difficult to perform deliberate infection experiments
and thus difficult to explore the underlying mechanisms.
Some breeds have exhibited greater resistance than others
(Opriessnig et al., 2006), but again this is mostly circum-
stantial and difficult to quantify. Therefore although this is
a very important disease, at present there is no published
evidence of genetic variation in the incidence or severity of
PMWS and it is not yet a candidate disease for OG.
Salmonella spp.
Salmonella incidence figures in humans (EFSA, 2005 and
2006) are described in the poultry section of this report;
unfortunately, the total numbers of cases are not split into
species from which the infection originated. The most
relevant Salmonella serovar affecting pigs is S. typhimur-
ium; however, the swine-specific serovar S. choleraesuis
also plays an important role. Salmonella is usually seen in
young growing pigs, 12–14 weeks of age, and infects the
gut, causing diarrhoea. This infection is of industry and
public health concern as it is a food-borne zoonosis that can
cause food poisoning in humans. Infection can also be sub-
clinical in the pig; hence if the infection is not treated,
the risk of passing the infection to humans is increased.
Sub-clinical infection also causes general production losses.
Evidence for genetic variation in response to Salmonella
between lines was reported by Van Diemen et al. (2002).
Also, several recent gene expression studies using microarrays
(Niewold et al., 2007; Uthe et al., 2007; Wang et al., 2007)
and the SSH technology (Uthe et al., 2006) revealed important
genes involved in the host immune response against both
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S. typhimurium and S. choleraesuis. Due to these advances,
swine Salmonella is a good OG candidate pathogen.
Summary
Table 3 shows a summary of the nine pig pathogens and
diseases, ranked as previously described. The highest priority
diseases or pathogens highlighted by this approach are
E. coli, PRRS and Salmonella, broadly reflecting ongoing
research efforts in Europe and North America. Once again
FMD is top ranking from a disease perspective, but it is not a
good candidate for an OG approach. From an industry per-
spective, PRRS and PMWS are probably the most important
health issues, but in both cases considerable further research
is required to define the biology of the disease. It is predicted
that the relative rankings assigned to these diseases will
increase as ongoing research yields further insights, as also as
the pig genome sequence becomes available.
Major infectious pathogens and diseases of sheep
Caseous lymphadenitis
Caseous lymphadenitis (CLA) is a bacterial disease caused by
infection with Carynebacterium pseudotuberculosis. It man-
ifests as caseous abscessation of the lymph nodes and internal
organs. CLA is a chronic recurring disease and some animals
may exhibit a carrier status. Initially abscesses develop at the
point of entry of the bacterium, or on local lymph nodes, the
infection then spreads to internal organs and other lymph
nodes. Economic losses occur as a result of reduced weight
gain, reproductive efficiency, and milk and wool production.
Treatment of CLA is not usually attempted as affected car-
casses are condemned. Prevention is based on reducing
transmission to healthy stock via isolation and selective cul-
ling. CLA is not suitable for an OG study as there is no
knowledge at present of the underlying host genetic control.
Chlamydial abortion
Chlamydial abortion is caused by the bacteria Chlamydia
psittaci. It manifests as either abortion in late gestation or
an increase in stillborn lambs in an infected flock. Surviving
lambs are often weak. Control is by isolation of infected
ewes and lambs and antibiotic treatment; however, ewes
seldom abort from Chlamydial abortion more than once.
Congenital infection can occur and infected ewe lambs will
abort the first pregnancy. This disease causes significant
economic loss; the estimated annual cost in GB is £20
million, excluding the cost to human health (Bennett and
Ijpelaar, 2003). This disease also presents a public health
hazard as it is zoonotic; it can cause flu-like symptoms and
abortion in humans. However, no evidence for host genetic
variation in susceptibility has been reported and currently
this condition is not suitable for an OG approach.
Contagious ovine digital dermatitis
Contagious ovine digital dermatitis (CODD) is a bacterial
infection that causes severe lameness, with per-animal costs
being similar to those for footrot (see below). Ulcerative
lesions form on the hoof, which, in severe cases, can lead to
detachment of the hoof. Although appearing similar to classic
footrot, CODD differs in the site of the lesions and no inter-
digital damage occurs. Treatment requires specific antibiotics.
At present no single bacterium has been identified as the
causative agent of CODD. However, several bacteria have been
identified from clinical cases; these include Spirochaetes,
similar to organisms causing digital dermatitis in cattle, and
Dichelobacter nodosus, a causative agent for ovine footrot. At
present, the causative agent is yet to be defined and there is
no evidence for genetic variation in resistance to CODD.
Therefore, CODD is not a potential disease for an OG study.
Foot and mouth disease
Please refer to the cattle section for a description of FMD.
Although FMD has similar effects in different species, the
scores assigned to FMD vary between species.
Footrot
Footrot is a specific, chronic, necrotising disease of the
epidermis of the inter-digital skin and hoof matrix, which
Table 3 List and scores1 of infectious pig diseases
Pathogen/disease
Industry
concern
Economic
impact
Public
concern
Zoonotic
potential
Animal
welfare
International
trade
Disease
score
Genetic
variation
OG rank
within species
OG rank
across species
E. coli 2 2 3 3 1 11 3 4.8 6.8
PRRS 3 3 1 1 3 11 2 3.8 5.8
Salmonella spp. 2 2 3 3 1 11 2 3.8 5.8
Aujeszky’s disease 3 3 1 7 2 3.2 5.2
PMWS 3 3 1 1 3 11 1 2.8 4.8
FMD 1 3 3 3 3 13 2.2 4.2
Enzootic pneumonia 1 1 1 1 4 1 1.7 3.7
Atrophic rhinitis 2 2 3 7 1.2 3.2
Porcine flu 2 3 1 6 1 3
OG5 operational genomics; PRRS5 porcine reproductive and respiratory syndrome; PMWS5 post weaning multisystemic wasting syndrome; FMD5 foot and
mouth disease.
1The scores (1, 2 or 3) indicate the relative strength of evidence, impact, concern or threat posed by each disease, with an absence of evidence indicated by no
assigned value.
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causes lameness in sheep. It has two causative bacterial
agents, Fusobacteria necrophorum and Dichelobacter (Bacter-
oides) nodosus, which act synergistically. Footrot is contagious
and moist soil conditions contribute greatly to the cause and
spread. In an infected flock, morbidity may reach 100%.
Footrot causes significant economic loss and the estimated
annual cost of footrot in GB is £24 million (Nieuwhof and
Bishop, 2005). Treatment of footrot is normally with antibiotics
or topical soaking (footbath) with detergents. However, evi-
dence of heritable genetic variation has been reported
(Raadsma et al., 1994; Nieuwhof et al., 2008), and associa-
tions have been observed with MHC class II genes, in parti-
cular the DQA2 gene. This gene is used in New Zealand as a
marker for footrot resistance, and is now commercially avail-
able (Hickford et al., 2004). Due to the high prevalence, easy
diagnosis and availability of host genetic data, Footrot is a
potentially suitable candidate for an OG study.
Gastrointestinal parasites
GI parasites infect all grazing sheep and cause a loss of
production through damage to the GI tract, which results in
reduced nutrient uptake and retention. In GB the estimated
annual cost of GI parasites is £84 million (Nieuwhof and
Bishop, 2005). Throughout the EU member states different
GI parasites (predominantly nematodes) will be prevalent
depending on climatic factors; however, all cause significant
production losses. Management of GI parasites is normally
through anthelmintic treatment; however, anthelmintic
resistance is a worldwide problem and resistance has now
been reported to every commercially available group of
anthelmintics. Routine use of anthelmintics also raises
consumer concern as whole flocks are treated at regular
intervals, regardless of infection status, thus increasing the
risk of drug residues in food products.
Many studies have reported evidence of genetic variation
to parasite resistance (see reviews by Dominik, 2005;
Davies et al., 2006; Bishop and Morris, 2007). Breed
differences exist and considerable within-breed genetic
variation has been reported, although the work reported
involves a diverse range of parasites in many different
breeds in differing production systems. Several QTL have
now been identified, some within the MHC region, which
provide evidence to suggest that it may be possible to
increase resistance to parasites by using selective breeding
protocols, such as marker-assisted selection or genomic
selection. GI parasitic infections are a suitable condition for
an OG study as there is strong evidence for genetic varia-
tion, relative levels of resistance are easily assessed and
there is a growing concern within industry to find alter-
native control strategies.
Maedi visna
Maedi visna (MV) is a chronic viral disease that occurs in
most sheep-producing countries. Clinical signs include
pneumonia, wasting, arthritis, chronic mastitis and pro-
gressive paralysis. MV has a long incubation period, is
highly contagious, difficult to diagnose and at present no
treatment is available. In an affected flock, mortality can
reach 20% and the incidence of arthritis and premature
births increases along with reduced conception rates. Breed
differences for susceptibility and resistance to MV have
been reported (Cutlip et al., 1986); however, much of the
evidence appeared to be anecdotal and few published
studies were found. Thus MV is not a suitable candidate for
an OG study at the present time.
Mastitis
Please refer to the cattle section for a disease description of
mastitis. The most common bacteria causing mastitis in
sheep are Staphylococcus spp., E. coli and M. haemolytica;
Streptococcus spp. and Carynebacterium pyogenes are
other relevant causative organisms. Mastitis is an eco-
nomically important disease in dairy sheep with an inci-
dence.2%. In meat sheep it can cause depressed weaning
weights due to a drop in milk production and altered
suckling behaviour (Gougoulis et al., 2008), with lamb
mortality from starvation in extreme cases. Mastitis can be
treated with antibiotics; however, this increases public
concern regarding drug use in animal production.
SCC, an indicator of sub-clinical infections, has been
shown to be heritable (normally 0.1 to 0.2) in many studies.
Recent results demonstrate that there is genetic variation in
sheep susceptibility to the disease (Fragkou et al., 2007)
and that teeth disorders clearly favour mastitis inflamma-
tion in ewes (Mavrogianni and Fthenakis, 2007). QTL have
been identified in traits that are known to influence mastitis
susceptibility and resistance (Barillet et al., 2005). Also,
genetic parameters and correlations indicated that udders
with good shape are less prone to sub-clinical mastitis
(Legarra and Ugarte, 2005). This is a candidate disease for
OG studies, as evidence of genetic variation has been
reported and the phenotypes associated with the disease
are well described.
Pneumonia
Pneumonia is a major cause of mortality in lambs. It is
predominantly caused by infection with M. haemolytica, a
weakly haemolytic, Gram-negative coccobacillus. Clinical
signs include fever, increased respiratory rate, failure to
feed and if left untreated it can cause death. Susceptibility
to pneumonia is increased with a lack of colostrum and
infected lambs appear sick and unthrifty. Antibiotic treat-
ment is available; however, this must be administered as
early as possible for maximum chance of recovery. It is
often common practice to treat all lambs exposed to an
infected animal. This raises public concern regarding drug
use and also animal welfare issues regarding therapeutic
prophylactic treatment. At present there is no published
evidence for genetic variation for resistance to pneumonia,
and it is not a suitable disease for an OG study.
Sheep scab
Sheep scab is an infectious skin condition caused by an
infestation of Psoroptes ovis mites. Infection with sheep
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scab manifests as large, scaly, crusted lesions that progress
to intense pruritus, due to biting and scratching. If left
untreated, animals become emaciated and anaemic with
associated production losses. This condition may be treated
and controlled by the use of acaricidal dips or the use of
broad-spectrum avermectins, but again this raises issues of
increasing the risk of drug residues in animal products.
Sheep scab causes significant economic loss and the esti-
mated annual cost in GB is £8.3 million (Nieuwhof and
Bishop, 2005). As yet no genetic variation has been
reported in resistance to Psoroptes mite; thus this is not a
suitable condition for OG.
Toxoplasmosis
Toxoplasmosis is caused by infection with a protozoan para-
site, Toxoplasma gondii. This parasite causes abortion; ewes
infected in early gestation may exhibit resorption and mum-
mification of foetuses, whereas infection in late gestation
results in abortion or perinatal death. Infected ewes do not
appear to be ill and once infected develop lifelong immunity.
Economic losses are due to reduced reproductive efficiency
and aborted and weak lambs. The estimated annual cost of
Toxoplasmosis in GB is £12 million (Bennett and Ijpelaar,
2003). This disease is of public health concern as T. gondii is
zoonotic and may cause flu-like clinical signs and abortion in
humans. A total of 1736 human cases of toxoplasmosis were
reported in 2004 (EFSA, 2005). No evidence for host genetic
variation associated with resistance to this parasite has been
published; therefore Toxoplasmosis is not a suitable candidate
disease for OG.
Summary
Table 4 shows a summary of the 11 sheep pathogens and
diseases, ranked as previously described. The highest-
ranking diseases were mastitis (dairy sheep) and GI para-
sites, largely reflecting ongoing research activities, although
footrot and mastitis in meat sheep also offer good oppor-
tunities. Sheep are characterised by a number of diseases of
major importance to the industry, for which evidence of
host genetic effects is lacking. This is not to say that such
variation does not exist; rather, it has yet to be quantified.
Once again FMD ranks highest in terms of disease issues.
Major infectious pathogens and diseases of
Atlantic salmon
Infectious pancreatic necrosis
Infectious pancreatic necrosis (IPN) is the most economic-
ally important disease at present in Atlantic salmon. IPN is
endemic in the North Atlantic, as survivors can become
carriers, shedding the virus with faeces. This viral disease
causes major economic loss with current costs estimated at
£41 million/year in Norway and £2 million/year in Shetland.
Fish become infected between 6 and 12 weeks post transfer
to the sea environment and mortality is typically up to 30%.
This disease, however, has no zoonotic potential and is of
no risk to human health.
There is now strong evidence for genetic variation in IPN
resistance in salmon (Guy et al., 2006; Wetten et al., 2007)
and QTL have been successfully mapped for IPN resistance
(Houston et al., 2008). The viral genome has also been
sequenced for a couple of strains and all IPN virus isolates
appear to be genetically similar. However, the underlying
mechanisms of the carrier state are as yet unknown. IPN is
clearly a suitable disease for an OG study, hindered only by
the underdeveloped salmon genome tools.
Infectious salmon anaemia
Infectious salmon anaemia (ISA) is an infectious viral dis-
ease of Atlantic salmon. It has been a major problem to the
salmon industry in recent years but is now less prevalent
than IPN. Salmon are the only species to exhibit clinical
signs of disease, yet a carrier status has been observed in
trout. There is no zoonotic risk with this virus and thus no
threat to food safety. Clinical signs are lethargy, haemor-
rhagic eyes, pale gills and abdominal distension. Mortality
Table 4 List and scores1 of infectious sheep diseases
Pathogen/disease
Industry
concern
Economic
impact
Public
concern
Zoonotic
potential
Animal
welfare
International
trade
Disease
score
Genetic
variation
OG rank
within species
OG rank
across species
Mastitis (dairy sheep) 3 3 1 2 9 3 4.5 6.5
GI parasites 3 3 2 8 3 4.3 6.3
Footrot 2 2 2 6 3 4 6
Mastitis (meat sheep) 2 2 1 2 7 2 3.2 5.2
Maedi visna 2 2 2 6 1 2 4
FMD 2 3 2 2 3 12 2 4
CLA 3 3 2 3 11 1.8 3.8
Sheep scab 3 2 3 8 1.3 3.3
CODD 2 2 3 7 1.2 3.2
Toxoplasmosis 2 1 1 2 1 7 1.2 3.2
Pneumonia 2 2 2 6 1 3
Chlamydial abortion 2 1 1 1 1 6 1 3
OG5 operational genomics; GI5 gastrointestinal; FMD5 foot and mouth disease; CLA5 caseous lymphadenitis; CODD5 contagious ovine digital dermatitis.
1The scores (1, 2 or 3) indicate the relative strength of evidence, impact, concern or threat posed by each disease, with an absence of evidence indicated by no
assigned value.
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rates vary with outbreak although can reach 90%. This
disease is now less of a concern to industry as good bio-
security and regular removal of dead fish have brought
about a level of control.
Evidence of genetic variation has been reported, with
several QTL associated with this condition identified (Moen
et al., 2004). This condition may be a potential candidate
for an OG approach; however, industry concern has les-
sened as control measures have become more successful.
Salmon pancreatic disease
Salmon pancreatic disease (SPD) is an emerging econom-
ically important viral disease of farmed salmon. This dis-
ease, caused by the first alphavirus reported in fish, was
first seen in the UK in 1984, but is now present in salmon
across Europe. It causes loss of weight, emaciation, poor
growth and an increase in mortality. Much research has
been carried out on the virus, however, as yet not on the
host response. Because nothing appears to be published on
the host genetics underlying the response to this disease,
SPD is not an OG candidate at present.
Summary
Table 5 shows a summary of the three Atlantic salmon
pathogens and diseases, ranked as previously described. IPN is
clearly a strong OG candidate, and this is reflected by a large
body of research under way in the UK and Norway, as well as
practical breeding programmes that aim to increase popula-
tion-level resistance to this disease. But for decreasing industry
concern, ISA would also have been a high-ranking disease.
Discussion
This paper has presented a method of comparing the
impacts of different infectious diseases, using previously
suggested methodology, and shown how it may be com-
bined with additional information on host genetics in order
to rank diseases in terms of their importance and amen-
ability to research. It should be appreciated that the method
is somewhat subjective and based on expert opinion as well
as published data; therefore precise scores may be debated.
However, we believe that the approach is robust, pro-
vided that the scores allocated to diseases are updated as
further information becomes available or new resources are
developed. Further, the list of diseases, whilst extensive, is
not comprehensive and additional diseases may be added
to the list.
This methodology has been developed, and case studies
presented, from the perspective of dissecting host genetic
variation in resistance. Alternative perspectives could
also be applied, for example elucidation of host–pathogen
interactions with the aim of developing vaccine targets.
If this were done, the relative disease rankings would
change. Also, it is the dissection of host genetic variation
that has been considered, and not the application of such
information to disease control. The role of host genetics in
managing diseases will depend upon the other available
control options, and this perspective may well reduce the
ranking of some diseases, particularly in cases where
adequate and cost-effective vaccines exist.
A further dimension that has not been considered is the
ease with which disease data may be collected on sufficient
animals to do genetic studies. This will clearly differ
between species and diseases, generally being easiest for
endemic diseases. However, it is evident that large-scale
data collection will usually be easier, quicker and cheaper in
smaller host species, especially in Atlantic salmon where
several thousand individuals can be measured in one
experiment, than in larger host species. Even in the com-
parison between cattle and sheep, it is much quicker and
easier to generate adequate datasets describing GI parasite
resistance in sheep than in cattle.
The highest scored pathogen or disease, from an overall
OG perspective, was Salmonella in poultry, closely followed
by bovine mastitis and MD and coccidiosis in poultry.
Although we identified high-ranking diseases in all host
species, it should be noted that high-ranking diseases were
dominated by poultry diseases. Two reasons can be iden-
tified for this, firstly the advanced state of poultry genomic
tools and, possibly more importantly, the relative ease of
large-scale disease data collection in poultry. If genomic
tools for sheep were to improve to become equivalent to
those for cattle and poultry, then several sheep diseases
would be amongst the most amenable disease to OG
studies. Disease genetics research in Atlantic salmon is still
in its infancy, and strong conclusions are difficult to draw.
An interesting new application of genome tools is gen-
ome-wide selection. The principle is that individual animal
phenotypes are correlated with several thousand SNP
Table 5 List and scores1 of infectious Atlantic salmon disease
Pathogen/disease
Industry
concern
Economic
impact
Public
concern
Zoonotic
potential
Animal
welfare
International
trade
Disease
score
Genetic
variation
OG rank
within species
OG rank
across species
IPN 3 3 2 8 3 4.3 5.3
ISA 2 2 1 5 3 3.8 4.8
Pancreatic disease 3 2 1 6 1 2
OG5 operational genomics; IPN5 infectious pancreatic necrosis; ISA5 infectious salmon anaemia.
1The scores (1, 2 or 3) indicate the relative strength of evidence, impact, concern or threat posed by each disease, with an absence of evidence indicated by no
assigned value.
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genotypes, using a high-density SNP array. The results are
then used to predict the trait genotype of these individuals
or their relatives (e.g. progeny) without the need for further
phenotypic information. This clearly has a role in two dis-
ease scenarios, for widespread or predictable endemic
diseases, and for epidemics where DNA can be obtained
from disease and control animals. This will open new
opportunities for the dissection and utilisation of host
genetic variation in disease resistance, giving particular
attention to endemic diseases.
To conclude, we have developed and presented a classifi-
cation system for ranking infectious disease of livestock, from
the host genetic perspective. The obtained list reflects the
situation at present and, with some exceptions, the rankings
obtained do largely reflect ongoing research efforts. However,
this is a dynamic process that can change as more informa-
tion becomes available will augment. The ranking process
reported here and the criteria used may represent an inter-
esting tool for other similar comparative studies. Indeed, the
reported results and classification methodology might be a
basic source of information that is valuable to many groups.
For example, it may help researchers prioritise diseases for
future studies, also it should be a useful tool for funding
agencies when evaluating and prioritising specific projects for
their funding decisions.
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